Lars Stenbygaard
Impact in
- Cancer Research top 5%
- Breast Cancer Treatment Studies
- Oncology top 5%
- Cancer Risks and Factors
- Cancer Diagnosis and Treatment
Papers in
- Oncology 19
- Cancer Treatment and Pharmacology 6
- Cancer Diagnosis and Treatment 5
-
- Breast Cancer Treatment Studies 14
- Co-authors
- Erik Jakobsen (9 shared papers)Søren Cold (6 shared papers)Maj‐Britt Jensen (5 shared papers)Marianne Ewertz (3 shared papers)Dorte Nielsen (3 shared papers)Ulla Brix Tange (1 shared paper)Inger Højris (1 shared paper)K. Gunnarsdóttir (1 shared paper)
In The Last Decade
Lars Stenbygaard
29 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 70
- Cancer Research 516
- Oncology 657
- Radiation 177
- Pulmonary and Respiratory Medicine 305
- Pathology and Forensic Medicine 135
Countries citing papers authored by Lars Stenbygaard
This map shows the geographic impact of Lars Stenbygaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Stenbygaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Stenbygaard more than expected).
Fields of papers citing papers by Lars Stenbygaard
This network shows the impact of papers produced by Lars Stenbygaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Stenbygaard. The network helps show where Lars Stenbygaard may publish in the future.
Co-authors
The 25 scholars most cited alongside Lars Stenbygaard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 445 | |
| 2 | 2013 | 146 | |
| 3 | 2020 | 142 | |
| 4 | 1993 | 71 | |
| 5 | 2022 | 44 | |
| 6 | 1999 | 43 | |
| 7 | 2022 | 38 | |
| 8 | 1999 | 26 | |
| 9 | 2011 | 25 | |
| 10 | 2008 | 23 | |
| 11 | 1997 | 21 | |
| 12 | 2011 | 20 | |
| 13 | 1995 | 8 | |
| 14 | 2019 | 6 | |
| 15 | 1993 | 5 | |
| 16 | 1997 | 5 | |
| 17 | 2017 | 4 | |
| 18 | 2024 | 3 | |
| 19 | 2020 | 3 | |
| 20 | The DBCG RT NATURAL trial: Accelerated partial breast irradiation versus no irradiation for early stage breast cancer, a clinically controlled randomized phase III trial | 2018 | 3 |
About Lars Stenbygaard
Lars Stenbygaard is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Surgery, having authored 29 papers that have together received 1.1k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (14 papers), Cancer Treatment and Pharmacology (6 papers), Lung Cancer Treatments and Mutations (5 papers), Cancer Diagnosis and Treatment (5 papers), Medical Imaging Techniques and Applications (3 papers), Medical Imaging and Pathology Studies (3 papers), Advances in Oncology and Radiotherapy (3 papers) and Advanced Radiotherapy Techniques (3 papers). The work is most often cited by research in Cancer Research (516 citations), Oncology (657 citations), Radiation (177 citations), Pulmonary and Respiratory Medicine (305 citations) and Pathology and Forensic Medicine (135 citations). Lars Stenbygaard has collaborated with scholars based in Denmark, Germany and Norway. Frequent co-authors include Erik Jakobsen, Søren Cold, Maj‐Britt Jensen, Marianne Ewertz, Dorte Nielsen, Ulla Brix Tange, Inger Højris, K. Gunnarsdóttir, Mette Holck Nielsen and Birgitte Vrou Offersen. Their work appears in journals such as Journal of Clinical Oncology, Acta Oncologica, Radiotherapy and Oncology, Lung Cancer and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.